Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Süsal, C; Wettstein, D; Döhler, B; Morath, C; Ruhenstroth, A; Scherer, S; Tran, TH; Gombos, P; Schemmer, P; Wagner, E; Fehr, T; Živčić-Ćosić, S; Balen, S; Weimer, R; Slavcev, A; Bösmüller, C; Norman, DJ; Zeier, M; Opelz, G; Collaborative Transplant Study Report.
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
Transplantation. 2015; 99(9):1976-1980 Doi: 10.1097/TP.0000000000000672
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Schemmer Peter
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: The association of donor-specific HLA antibodies (DSA) with kidney graft failure has been addressed previously; however, the majority of studies were based on small numbers of patients with graft failure. We investigated 83 patients with failed kidney transplants for a possible association of de novo development and persistence or loss of pre-existing DSA with graft failure. Single Antigen Bead assay-detected DSA and non-DSA antibodies were compared between patients with graft loss and matched controls with functioning grafts. The incidence of weak de novo DSA or non-DSA at a mean fluorescence intensity of 500 or higher was higher in the graft loss than in the nonrejector group (76% vs 40%, P < 0.001). Because of the low number of patients developing de novo DSA, the DSA results did not reach statistical significance (only 22% of patients with graft loss developed de novo DSA). However, at all cutoffs, there was a significantly higher rate of graft loss in patients with de novo non-DSA. The incidence of strong pretransplant DSA that persist after transplantation was higher in the graft loss group (10% vs 1%, P = 0.034). When C1q-binding ability in sera of rejectors and nonrejectors with posttransplant de novo or persistent DSA was compared, none of the nonrejectors demonstrated C1q positivity, whereas 43% of patients with graft loss showed C1q-positive antibodies, although not necessarily donor-specific (P < 0.001). Our data show that the posttransplant presence of persisting or de novo HLA antibodies, especially if C1q binding, is associated with graft loss, even if the antibodies are not specific for mismatched donor HLA.
Find related publications in this database (using NLM MeSH Indexing): Adolescent -; Adult -; Aged -; Biomarkers - blood; Complement C1q - immunology; Female -; Graft Rejection - blood; Graft Rejection - diagnosis; Graft Rejection - immunology; HLA Antigens - immunology; Histocompatibility -; Histocompatibility Testing - methods; Humans -; Isoantibodies - blood; Kidney Transplantation - adverse effects; Male -; Middle Aged -; Predictive Value of Tests -; Retrospective Studies -; Risk Factors -; Serologic Tests -; Treatment Outcome -; Young Adult -